European Commission Argues Against Revealing Vaccine Negotiators to Protect Staff From Targeted Antivax Harassment

EU vaccine contracts face scrutiny as the Commission fights a court order to name negotiators, citing harassment risks from theorists and skeptics.

By: AXL Media

Published: Mar 4, 2026, 9:57 AM EST

Source: Information for this report was sourced from Politico

The Defense of Administrative Privacy

Legal representatives for the European Commission appeared before the Court of Justice of the EU to challenge a prior mandate requiring the disclosure of identities behind pandemic-era pharmaceutical contracts. Antonios Bouchagiar, acting as counsel for the Commission, emphasized that officials involved in high-stakes negotiations with Big Pharma face a credible threat of being targeted by extremist groups. The executive branch maintains that shielding these individuals is a necessary measure to prevent "physical or psychological" harassment from those fueled by a lack of trust in public health institutions.

The Push for Institutional Accountability

The current proceedings stem from a 2024 General Court decision which asserted that the public interest in transparency outweighed the privacy concerns of the negotiating teams. According to the previous ruling, identifying the specific civil servants involved was the only viable method for the public to verify the absence of professional conflicts of interest. A coalition of Green MEPs and thousands of private citizens initiated the challenge, arguing that the massive scale of the public expenditure required the highest level of scrutiny rather than the heavily redacted documents initially provided.

Constitutional Values in Times of Crisis

During the hearing in Luxembourg, legal teams representing European lawmakers argued that transparency is not merely a preference but a fundamental constitutional value within the bloc. Raluca Gherghinaru, representing the MEPs, stated that accountability should increase rather than diminish during periods of global emergency. The argument suggests that while the Commission claims to have protected its staff, it has simultaneously eroded public confidence by withholding the names of those who orchestrated the advance purchase agreements for millions of vaccine doses.